{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:09:31Z","timestamp":1791223771930,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.jcv.2008.07.001","type":"journal-article","created":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T14:18:03Z","timestamp":1220019483000},"page":"212-215","source":"Crossref","is-referenced-by-count":9,"title":["Foscarnet salvage therapy efficacy is associated with the presence of thymidine-associated mutations (TAMs) in HIV-infected patients"],"prefix":"10.1016","volume":"43","author":[{"given":"Charlotte","family":"Charpentier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Laureillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Sodqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Si-Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Karmochkine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"B\u00e9lec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Piketty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2008.07.001_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/infdis\/172.1.225","article-title":"Foscarnet decreases human immunodeficiency virus RNA","volume":"172","author":"Kaiser","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcv.2008.07.001_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00042560-199805010-00007","article-title":"Foscarnet decreases HIV-1 plasma load","volume":"18","author":"Devianne-Garrigue","year":"1998","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jcv.2008.07.001_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00042560-199805010-00008","article-title":"Pronounced anti-HIV-1 activity of foscarnet in patients without cytomegalovirus infection","volume":"18","author":"Bergdahl","year":"1998","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jcv.2008.07.001_bib4","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00002030-200404300-00020","article-title":"Foscarnet used in salvage therapy of HIV-1 patients harbouring multiple nucleotide excision mutations","volume":"18","author":"Mathiesen","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.jcv.2008.07.001_bib5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/135965350601100501","article-title":"Foscarnet salvage therapy for patients with late-stage HIV disease and multiple drug resistance","volume":"11","author":"Canestri","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jcv.2008.07.001_bib6","doi-asserted-by":"crossref","first-page":"27744","DOI":"10.1074\/jbc.M603360200","article-title":"Selective excision of chain-terminating nucleotides by HIV-1 reverse transcriptase with phosphonoformate as substrate","volume":"281","author":"Cruchaga","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcv.2008.07.001_bib7","doi-asserted-by":"crossref","first-page":"7171","DOI":"10.1128\/JVI.70.10.7171-7181.1996","article-title":"Zidovudine resistance is suppressed by mutations conferring resistance of human immunodeficiency virus type 1 to foscarnet","volume":"70","author":"Tachedjian","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2008.07.001_bib8","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1128\/JVI.77.11.6127-6137.2003","article-title":"Relationship between 3\u2032-azido-3\u2032-deoxythymidine resistance and primer unblocking activity in foscarnet-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase","volume":"77","author":"Meyer","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.jcv.2008.07.001_bib9","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1128\/AAC.45.6.1621-1628.2001","article-title":"Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance","volume":"45","author":"Hammond","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcv.2008.07.001_bib10","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1128\/AAC.39.5.1087","article-title":"Novel mutations in reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates","volume":"39","author":"Mellors","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcv.2008.07.001_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/viro.1995.1453","article-title":"Characterisation of foscarnet-resistant strains of human immunodeficiency virus type 1","volume":"212","author":"Tachedjian","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.jcv.2008.07.001_bib12","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJM199512213332502","article-title":"Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimetre. North American HIV Working Party","volume":"333","author":"Eron","year":"1995","journal-title":"N Engl J Med"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653208002461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653208002461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T19:52:23Z","timestamp":1684525943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653208002461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1386653208002461"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2008.07.001","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}